New research published in JAMA Pediatrics suggests that semaglutide-based medications, such as Ozempic and Wegovy, may help improve mental health in obese adolescents. The study, which tracked 4,000 teens aged 12 to 19 over a 12-month period, found a 33% reduction in suicidal thoughts and behaviors among those taking the medication.
Key Findings
- Long-term benefits of the drug were observed up to three years after use.
- The study challenges previous concerns that semaglutide may trigger suicidal thoughts.
- The medication has been linked to improved emotional well-being, possibly due to weight loss and increased self-esteem.
While the findings are promising, experts caution that more research is needed to fully understand the drug’s long-term effects on mental health. With obesity rates rising among teenagers, semaglutide could provide both physical and psychological benefits, offering a new perspective on weight loss treatments.
For more details, visit New York Post.
